Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccine
Scientists at GlaxoSmithKline release new data on vaccine
September 3rd, 2008
According to recent research from Rixensart, Belgium, "Multiple pathogens may cause pneumonia. Three vaccines with demonstrated or potentially major impact on paediatric pneumonia caused by pneumococcus and/or non-typable Haemophilus influenzae (NTHi) are projected to soon become globally available." "Estimating the magnitude of this impact requires precise knowledge of the etiology of pneumonia. We reviewed studies to evaluate the relative importance of specific pneumococcal serotypes and NTHi as pneumonia pathogens," wrote W.P. Hausdorff and colleagues, GlaxoSmithKline. The researchers concluded: "While emerging conjugate vaccines, especially those...
Source: Vaccine Weekly (2008-09-03)
|
